Description
- Moisturizing face cream with sun protection
- Day cream with SPF25
- Thin texture
- For normal to dry skin
- With hyaluronic acid, niacinamide and ceramides
- With the patented MVE technology for prolonged hydration
- Does not cause imperfections, hypoallergenic, odorless
- Developed in collaboration with dermatologists
CeraVe Facial Moisturizing Lotion AM SPF25 is a moisturizing, sunscreen face cream for normal, dry and sensitive skin, for prolonged hydration.
CeraVe Moisturizing Lotion contains hyaluronic acid and ceramides that replenish the necessary elements of the skin barrier. It also offers niacinamide, which instantly strengthens the skin barrier and soothes the skin effectively.
Ceramides are lipids that are naturally present in the skin and are essential for strengthening the skin barrier and retaining moisture. Without ceramides, the skin becomes dry and irritated.
The combination of active ingredients contributes to the effective hydration and restoration of dry and damaged skin. It is absorbed instantly, based on a non-greasy composition with patented MVE diffusion technology that continuously releases hyaluronic acid and three essential ceramides throughout the 24-hour period.
In addition, it is tolerated by all skins, does not clog pores, being the most suitable moisturizing agent for sensitive and irritated by dry skin. It is noted that it enhances the elasticity of the epidermal barrier, while improving its density, appearance and texture.
It is a fragrance-free, hypoallergenic, non-itchy product, suitable for sensitive skin.
Instructions of use
Apply the face cream freely, as many times as needed during the day.
Properties
- Moisturizes deeply
- Protects against UVA and UVB radiation
- It does not cause imperfections
- It does not lubricate the skin
- Helps to restore and maintain the epidermal barrier
Skin type
For normal to dry skin.
Age
For all ages.
Cautions
Avoid the eye area. In case of contact with eyes, rinse immediately with plenty of water.
Reviews
There are no reviews yet.